a new serum biomarker of sarcoidosis(passive) discovered bya new serum biomarker of sarcoidosis
to improvements in the reliability and efficiency of semiconductor power devicesleadsto improvements in the reliability and efficiency of semiconductor power devices
to the identification of 2 novel biomarkers that should facilitate molecular diagnosis and further study of pulmonary neuroendocrine tumorsledto the identification of 2 novel biomarkers that should facilitate molecular diagnosis and further study of pulmonary neuroendocrine tumors
on the surfaceoriginatingon the surface
to useful biomarkersmay leadto useful biomarkers
in the diagnosis of viral meningitisresultedin the diagnosis of viral meningitis
to the accuracy of the diagnosisalso contributesto the accuracy of the diagnosis
and programmeddesignedand programmed
to useful biomarkers for determining the efficacy of standard treatment for CD and for providing additional tests for early detection of CDmay leadto useful biomarkers for determining the efficacy of standard treatment for CD and for providing additional tests for early detection of CD
to useful biomarkers for determining the efficacy of standard treatment for Crohn 's disease and for providing additional tests for early detectionmay leadto useful biomarkers for determining the efficacy of standard treatment for Crohn 's disease and for providing additional tests for early detection
to meetis designedto meet
in different estimates than in Chart 1can resultin different estimates than in Chart 1
to the identification of several factors that interact specifically with one subfamilyledto the identification of several factors that interact specifically with one subfamily
to the identification of several cellular mechanisms capable of initiating chromothripsis processhas also ledto the identification of several cellular mechanisms capable of initiating chromothripsis process
in identification of genetic variants or Single Nucleotide Polymorphisms ( SNPsresultingin identification of genetic variants or Single Nucleotide Polymorphisms ( SNPs
to the development of a classifier formed exclusively by AMPs which recognizes patients with BC with a sensitivity of 88 % and a specificity of 68 %ledto the development of a classifier formed exclusively by AMPs which recognizes patients with BC with a sensitivity of 88 % and a specificity of 68 %
to the identification of several factors that interact specifically with one subfamily , but not the other ( Behrends et al . , 2010ledto the identification of several factors that interact specifically with one subfamily , but not the other ( Behrends et al . , 2010
nothing to do with recent use of words indicating causal links such as neutropenia , renal transplantation , or obstructioncontributesnothing to do with recent use of words indicating causal links such as neutropenia , renal transplantation , or obstruction
the diagnostic classification of dementiamay influencethe diagnostic classification of dementia
from our Oncology centerresultsfrom our Oncology center
from our Oncology center obtained over two years and report three cases of gastric adenocarcinoma with cytologically positive CSFresultsfrom our Oncology center obtained over two years and report three cases of gastric adenocarcinoma with cytologically positive CSF